The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(benzo[d]thiazol-2-ylamino)-2-oxo-1-o-tolylethanesulfonic acid ID: ALA4796109
PubChem CID: 162674026
Max Phase: Preclinical
Molecular Formula: C16H14N2O4S2
Molecular Weight: 362.43
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccccc1C(C(=O)Nc1nc2ccccc2s1)S(=O)(=O)O
Standard InChI: InChI=1S/C16H14N2O4S2/c1-10-6-2-3-7-11(10)14(24(20,21)22)15(19)18-16-17-12-8-4-5-9-13(12)23-16/h2-9,14H,1H3,(H,17,18,19)(H,20,21,22)
Standard InChI Key: FZLUKTGHBBTCAH-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
3.5453 -17.7760 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3625 -17.7760 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.9539 -17.0683 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.2479 -19.0100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2468 -19.8295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9548 -20.2385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6645 -19.8290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6617 -19.0064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9530 -18.6011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3678 -18.5951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0771 -19.0010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0709 -17.3667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.7832 -18.5898 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4925 -18.9957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0801 -19.8182 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.5788 -19.8079 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2356 -18.6604 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.7847 -19.2655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3776 -19.9732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7868 -20.6775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6030 -20.6753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0082 -19.9630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5967 -19.2616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9506 -17.7839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
8 10 1 0
10 11 1 0
10 2 1 0
2 12 1 0
11 13 1 0
13 14 1 0
11 15 2 0
14 16 2 0
16 19 1 0
18 17 1 0
17 14 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
9 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 362.43Molecular Weight (Monoisotopic): 362.0395AlogP: 3.17#Rotatable Bonds: 4Polar Surface Area: 96.36Molecular Species: ACIDHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: -1.26CX Basic pKa: ┄CX LogP: 2.48CX LogD: 1.15Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.70Np Likeness Score: -1.54
References 1. He R,Wang J,Yu ZH,Zhang RY,Liu S,Wu L,Zhang ZY. (2016) Inhibition of Low Molecular Weight Protein Tyrosine Phosphatase by an Induced-Fit Mechanism., 59 (19.0): [PMID:27676368 ] [10.1021/acs.jmedchem.6b00993 ] 2. Forghieri, Marco M and 8 more authors. 2009-04-01 Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors. [PMID:19297174 ] 3. He, Yantao Y and 11 more authors. 2013-06-27 A potent and selective small-molecule inhibitor for the lymphoid-specific tyrosine phosphatase (LYP), a target associated with autoimmune diseases. [PMID:23713581 ] 4. He, Rongjun R and 6 more authors. 2016-10-13 Inhibition of Low Molecular Weight Protein Tyrosine Phosphatase by an Induced-Fit Mechanism. [PMID:27676368 ]